Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to investigate, using functional magnetic resonance imaging
(fMRI), the effect of treatment with lorcaserin on centers of the brain that control appetite
and food intake, as well as lorcaserin's downstream metabolic effects.